Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BONE-MARROW SUPPORT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 114 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sen, M; Wankowski, DM; Garlie, NK; Siebenlist, RE; Van Epps, D; LeFever, AV; Lum, LG
      Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Mayer, A; Earl, H
      Whither high-dose chemotherapy in breast cancer?

      BREAST CANCER RESEARCH
    3. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Pujade-Lauraine, E; Cure, H; Battista, C; Guastalla, JP; Chiurazzi, B; Fabbro, M; Tubiana-Mathieu, N; Bourgeois, H; Lioure, B; Paraiso, D; Lotz, JP
      High dose chemotherapy in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    5. Antman, KH
      A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer

      EUROPEAN JOURNAL OF CANCER
    6. Weiss, RB; Gill, GG; Hudis, CA
      An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications

      JOURNAL OF CLINICAL ONCOLOGY
    7. Antman, KH
      Randomized trials of high dose chemotherapy for breast cancer

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    8. De Rosa, L; Lalle, M; Perillo, A; Pierelli, L; Salerno, MG; Cortesi, E; Martelli, O; Pandolfi, A; Amodeo, R; Marzetti, L; Mancuso, S; Scambia, G
      Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer

      ANTICANCER RESEARCH
    9. Miller, KD; Sledge, GW
      High-dose chemotherapy in breast cancer - The perils of history uncontrolled

      MEDSCAPE WOMENS HEALTH
    10. Jillella, AP; Britt, GW; Litaker, MS; Kallab, AM; Harkness, K; Garner, GD
      Ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer

      MEDICAL ONCOLOGY
    11. Antman, KH
      High-dose chemotherapy in breast cancer: The end of the beginning?

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Nieto, Y; Champlin, RE; Wingard, JR; Vredenburgh, JJ; Elias, AD; Richardson, PR; Glaspy, J; Jones, RB; Stiff, PJ; Bearman, SI; Cagnoni, PJ; McSweeney, PA; LeMaistre, CF; Pecora, AL; Shpall, EJ
      Status of high-dose chemotherapy for breast cancer: A review

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    13. Damon, LE; Hu, WW; Stockerl-Goldstein, KE; Blume, KG; Wolf, JL; Gold, E; Cecchi, GR; Irwin, D; Glaspy, J; Territo, M; Miller, W; Mason, JR; Linker, CA
      High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    14. Frei, E; Ara, G; Teicher, B; Bunnell, C; Richardson, P; Wheeler, C; Tew, K; Elias, A
      Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    15. Bashey, A; Corringham, S; Garrett, J; Lane, TA; Gilpin, EA; Corringham, RET; Law, P; Ho, AD
      A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

      BONE MARROW TRANSPLANTATION
    16. Weiss, RB; Rifkin, RM; Stewart, FM; Theriault, RL; Williams, LA; Herman, AA; Beveridge, RA
      High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

      LANCET
    17. Goerner, M; Wandt, H; Schafer-Eckart, K; Birkmann, J; Denzel, T; Gallmeier, WM
      The use of CD34(+)-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    18. Nieto, Y; Cagnoni, PJ; Shpall, EJ; Matthes, S; Baron, A; Jones, RB; Bearman, SI
      Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease

      CLINICAL CANCER RESEARCH
    19. Hochster, H; Strawderman, MH; Harris, JE; Atkins, MB; Oken, M; Skeel, RT; Jubelirer, SJ; Parkinson, D
      Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687)

      ANTI-CANCER DRUGS
    20. MacNeil, M; Eisenhauer, EA
      High-dose chemotherapy: Is it standard management for any common solid tumor?

      ANNALS OF ONCOLOGY
    21. Adkins, D; Brown, R; Trinkaus, K; Maziarz, R; Luedke, S; Freytes, C; Needles, B; Wienski, D; Fracasso, P; Pluard, T; Moriconi, W; Ryan, T; Hoelzer, K; Safdar, S; Rearden, T; Rodriguez, G; Khoury, H; Vij, R; DiPersio, J
      Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    22. Rizzieri, DA; Vredenburgh, JJ; Jones, R; Ross, M; Shpall, EJ; Hussein, A; Broadwater, G; Berry, D; Petros, WP; Gilbert, C; Affronti, ML; Coniglio, D; Rubin, P; Elkordy, M; Long, GD; Chao, NJ; Peters, WP
      Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support

      JOURNAL OF CLINICAL ONCOLOGY
    23. Hohaus, S; Martin, S; Schneeweiss, A; Voso, MT; Schlenk, RF; Wallwiener, D; Bastert, G; Haas, R
      Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Schwartzberg, LS; Birch, R; Tauer, KW; Leff, R; Greco, FA; Hainsworth, J; Raefsky, E; McAneny, B; Weaver, Z; West, J; Buckner, CD; Weaver, CH
      Adjuvant dose-intense chemotherapy with peripheral blood stem cell supportin stage II-III breast cancer with five to nine involved axillary lymph nodes

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    25. Rowlings, PA; Williams, SF; Antman, KH; Fields, KK; Fay, JW; Reed, E; Pelz, CJ; Klein, JP; Sobocinski, KA; Kennedy, MJ; Freytes, CO; McCarthy, PL; Herzig, RH; Stadtmauer, EA; Lazarus, HM; Pecora, AL; Bitran, JD; Wolff, SN; Gale, RP; Armitage, JO; Vaughan, WP; Spitzer, G; Horowitz, MM
      Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    26. English, MW; Skinner, R; Pearson, ADJ; Price, L; Wyllie, R; Craft, AW
      Dose-related nephrotoxicity of carboplatin in children

      BRITISH JOURNAL OF CANCER
    27. PUSZTAI L; HORTOBAGYI GN
      HIGH-DOSE CHEMOTHERAPY - HOW RESISTANT IS BREAST-CANCER

      DRUG RESISTANCE UPDATES
    28. ELIAS AD; WHEELER C; AYASH LJ; SCHWARTZ G; IBRAHIM J; MILLS L; MCCAULEY M; COLEMAN N; WARREN D; SCHNIPPER L; ANTMAN KH; TEICHER BA; FREI E
      DOSE-ESCALATION OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE COMBINED WITH IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT

      Clinical cancer research
    29. GLUCK S; GERMOND C; LOPEZ P; CANO P; DORREEN M; KOSKI T; ARNOLD A; DULUDE H; GALLANT G
      A PHASE-I TRIAL OF HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE AND MITOXANTRONE WITH AUTOLOGOUS BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF METASTATIC BREAST-CANCER

      European journal of cancer
    30. DIAZCANTON EA; VALERO V; RAHMAN Z; RODRIGUEZMONGE E; FRYE D; SMITH T; BUZDAR AU; HORTOBAGYI GN
      CLINICAL COURSE OF BREAST-CANCER PATIENTS WITH METASTASES CONFINED TOTHE LUNGS TREATED WITH CHEMOTHERAPY

      Annals of oncology
    31. FETSCHER S; MERTELSMANN K
      THE CLINICAL ROLE OF GROWTH-FACTORS IN THE TREATMENT OF BREAST-CANCER

      Biomedicine & pharmacotherapy
    32. CAGNONI PJ; NIETO Y; SHPALL EJ; BEARMAN SI; BARON AE; ROSS M; MATTHES S; DUNBAR SE; JONES RB
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS PART OF COMBINED-MODALITY THERAPY INPATIENTS WITH INFLAMMATORY BREAST-CANCER

      Journal of clinical oncology
    33. ADKINS DR; BROWN RA; DIPERSIO JF
      PATIENT SELECTION IN HIGH-DOSE TRIALS OF BREAST-CANCER

      Journal of clinical oncology
    34. SCHWARTZBERG LS; BIRCH R; WEST WH; TAUER KW; WITTLIN F; LEFF R; CAMPOS L; RYMER W; CARTER P; MANGUM M; GRECO FA; HAINSWORTH J; RAEFSKY E; BLANCO R; BUCKNER CD; WEAVER CH
      SEQUENTIAL TREATMENT INCLUDING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK STAGE II-III BREAST-CANCER - OUTPATIENT ADMINISTRATION IN COMMUNITY CANCER CENTERS

      American journal of clinical oncology
    35. MCGUIRE TR; TARANTOLO S; REED E
      PERIPHERAL-BLOOD PROGENITOR CELLS - ENABLING OUTPATIENT TRANSPLANTATION

      Pharmacotherapy
    36. LJUNGMAN P; BJORKSTRAND B; FORNANDER T; HOGLUND M; JULIUSSON G; LINDMAN H; MALMSTROM A; ROTSTEIN S; SODERBERG M; WILKING N; VILLMAN K; BERGH J
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE-IV BREAST-CANCER

      Bone marrow transplantation
    37. SCHWELLA N; RICK O; MEYER O; LOFFEL J; SCHLEICHER J; SERKE S; HUHN D; RIESS H
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS BY DISEASE-SPECIFICCHEMOTHERAPY IN PATIENTS WITH SOFT-TISSUE SARCOMA

      Bone marrow transplantation
    38. VIENS P; PENAULTLLORCA F; JACQUEMIER J; GRAVIS G; COWEN D; BERTUCCI F; HOUVENAEGHEL G; BLAISE D; MARANINCHI D
      HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR INFLAMMATORY BREAST-CANCER - PATHOLOGICAL RESPONSE AND OUTCOME

      Bone marrow transplantation
    39. Miller, BE; Delmonico, L; Vistisen, K; Miller, FR
      Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents

      CLINICAL & EXPERIMENTAL METASTASIS
    40. WORMANN B; MEDEN H; RIGGERT J; HUMPE A; WULF G; KOCH B; KOHLER M; KUHN W; HIDDEMANN W
      EARLY INTENSIVE AND MYELOABLATIVE ADJUVANT CHEMOTHERAPY IN WOMEN WITHHIGH-RISK BREAST-CANCER

      Anticancer research
    41. BROWN MS; STEMMER SM; SIMON JH; STEARS JC; JONES RB; CAGNONI PJ; SHEEDER JL
      WHITE-MATTER DISEASE INDUCED BY HIGH-DOSE CHEMOTHERAPY - LONGITUDINAL-STUDY WITH MR-IMAGING AND PROTON SPECTROSCOPY

      American journal of neuroradiology
    42. YEH KH; LIN MT; LIN DT; TANG JL; LUI LT; LIN JF; CHANG YS; CHENG AL; YU SC; CHANG KJ; CHEN YC
      HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS

      Breast cancer research and treatment
    43. HOHAUS S; WALLWIENER D; MARTIN S; VOSO MT; HUOBER J; FERSIS N; BASTERT G; HAAS R
      EFFICACY AND TOXICITY OF SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK BREAST-CANCER

      Seminars in oncology
    44. SEDLACEK TV; SPYROPOULUS P; CIFALDI R; GLASSBURN J; FISHER S
      WHOLE-ABDOMEN RADIATION-THERAPY AS SALVAGE TREATMENT FOR EPITHELIAL OVARIAN-CARCINOMA

      The cancer journal from Scientific American
    45. HAAS R; SCHMID H; HAHN U; HOHAUS S; GOLDSCHMIDT H; MUREA S; KAUFMANN M; WANNENMACHER M; WALLWIENER D; BASTERT G; HUNSTEIN W
      TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER

      European journal of cancer
    46. CARMICHAEL J; WALLING J
      ADVANCED BREAST-CANCER - INVESTIGATIONAL ROLE OF GEMCITABINE

      European journal of cancer
    47. BRUFMAN G; COLAJORI E; GHILEZAN N; LASSUS M; MARTONI A; PEREVODCHIKOVA N; TOSELLO C; VIARO D; ZIELINSKI C; KRAINER M; SALZER H; SCHULLER J; DITTRICH C; SCHEITHAUER W; ZAMAGNI C; AMBROSINI G; COLUCCI G; GENTILINI P; ZANIBONI A; PACINI P; BIANCO R; MUSTACCHI G; DAPRILE M; DEMATTEIS A; OLIVEIRA C; JORDAAN J; GUDGEON A; VANZYL J; RAKOWSKY E; INBAR M; RATH P; COHEN Y; SHANI A; FRIED G; HEGG R; NETO AB; BADER G; BRAGA RF; VITOC C; PUERTO VML; VALLE AE; SALAZAR JD; SANCHEZ JC; VILLELA GM; FOUNTZILAS G
      DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/

      Annals of oncology
    48. LEONARD RCF
      THE ADVANCEMENT OF HIGH-DOSE CHEMOTHERAPY AND DOSE INTENSIFICATION SCHEDULES

      Annals of oncology
    49. SOMLO G; DOROSHOW JH; FORMAN SJ; ODOMMARYON T; LEE J; CHOW W; HAMASAKI V; LEONG L; MORGAN R; MARGOLIN K; RASCHKO J; SHIBATA S; TETEF M; YEN Y; SIMPSON J; MOLINA A
      HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL

      Journal of clinical oncology
    50. STIFF PJ; BAYER R; KERGER C; POTKUL RK; MALHOTRA D; PEACE DJ; SMITH D; FISHER SG
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS TRANSPLANTATION FOR PERSISTENTRELAPSED OVARIAN-CANCER - A MULTIVARIATE-ANALYSIS OF SURVIVAL FOR 100CONSECUTIVELY TREATED PATIENTS/

      Journal of clinical oncology
    51. JOHANSEN MJ; MADDEN T; MEHRA RC; WOOD JG; RONDON G; BROWNE V; NEWMAN RA; CHAMPLIN RE
      PHASE-I PHARMACOKINETIC STUDY OF MULTICYCLE HIGH-DOSE CARBOPLATIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH CANCER

      Journal of clinical oncology
    52. RAHMAN ZU; FRYE DK; BUZDAR AU; SMITH TL; ASMAR L; CHAMPLIN RE; HORTOBAGYI GN
      IMPACT OF SELECTION PROCESS ON RESPONSE RATE AND LONG-TERM SURVIVAL OF POTENTIAL HIGH-DOSE CHEMOTHERAPY CANDIDATES TREATED WITH STANDARD-DOSE DOXORUBICIN-CONTAINING CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER

      Journal of clinical oncology
    53. TAKASHIMA S; SAEKI T; ADACHI I; WATANABE T; SASAKI Y; MURAI H; TABEI T; OGITA M; SANO M; KANDA K; SHIMOYAMA M
      A PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN (EPI) PLUS CYCLOPHOSPHAMIDE (CPA) WITH G-CSF FOR BREAST-CANCER PATIENTS WITH VISCERAL METASTASES OR HORMONE-INDEPENDENT TUMORS - A TRIAL OF THE JAPAN CLINICAL ONCOLOGY GROUP

      Japanese Journal of Clinical Oncology
    54. GLUCK S; DESROCHERS C; CANO C; DORREEN M; GERMOND C; GILL K; LOPEZ P; SINOFF C
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BLOOD-CELL TRANSPLANTATION - A SAFE AND EFFECTIVE OUTPATIENT APPROACH

      Bone marrow transplantation
    55. BEARMAN SI; OVERMOYER BA; BOLWELL BJ; TAYLOR CW; SHPALL EJ; CAGNONI PJ; MECHLING BE; RONK B; BARON AE; PURDY MH; ROSS M; JONES RB
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR PRIMARY BREAST-CANCER IN PATIENTS WITH 4-9 INVOLVED AXILLARY LYMPH-NODES

      Bone marrow transplantation
    56. WOO MH; IPPOLITI C; BRUTON J; MEHRA R; CHAMPLIN R; PRZEPIORKA D
      HEADACHE, CIRCUMORAL PARESTHESIA, AND FACIAL FLUSHING ASSOCIATED WITHHIGH-DOSE CARMUSTINE INFUSION

      Bone marrow transplantation
    57. WEAVER CH; WEST WH; SCHWARTZBERG LS; ALBERICO T; LEFF R; GRECO FA; HAINSWORTH J; BIRCH R; MCANENY B; MAGEE M; RAEFSKY E; KALMAN L; BUCKNER CD
      INDUCTION, MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), HIGH-DOSE CHEMOTHERAPY AND PBSC INFUSION IN PATIENTS WITH UNTREATED STAGE-IVBREAST-CANCER - OUTCOMES BY INTENT TO TREAT ANALYSES

      Bone marrow transplantation
    58. BENSINGER WI; SCHIFFMAN KS; HOLMBERG L; APPELBAUM FR; MAZIARZ R; MONTGOMERY P; ELLIS E; RIVKIN S; WEIDEN P; LILLEBY K; ROWLEY S; PETERSDORF S; KLARNET JP; NICHOLS W; HERTLER A; MCCROSKEY R; WEAVER CH; BUCKNER CD
      HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER

      Bone marrow transplantation
    59. FORD C; SPITZER G; REILLY W; ADKINS D
      A PHASE-II STUDY OF REPETITIVE CYCLES OF DOSE-INTENSE CARBOPLATIN PLUS PACLITAXEL CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELLS IN METASTATIC BREAST-CANCER

      Seminars in oncology
    60. GARRETT TJ; VAHDAT LT; KINNE DW
      SYSTEMIC ADJUVANT THERAPY OF BREAST-CANCER

      Journal of surgical oncology
    61. NITZ U
      STEM-CELL SUPPORTED HIGH-DOSE CHEMOTHERAP Y OF OVARIAN-CANCER

      Der Gynakologe
    62. BRUN B; BENCHALAL M; LEBAS C; PIEDBOIS P; LIN M; LEBOURGEOIS JP
      RESPONSE TO 2ND-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CARCINOMA PREVIOUSLY RESPONSIVE TO FIRST-LINE TREATMENT - PROGNOSTIC FACTORS

      Cancer
    63. LOTZ JP; PENE F; BOULEUC C; ANDRE T; GLIGOROV J; AVENIN D; ESTESO A; BELLAICHE A; MACOVEI C; MERAD Z; LAADEM A; VANICA R; IZRAEL V
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STE M-CELL SUPPORT FOR THE TREATMENT OF GYNECOLOGIC TUMORS IN ADULTS

      Contraception fertilite sexualite
    64. BITRAN JD; SAMUELS B; TRUJILLO Y; KLEIN L; SCHROEDER L; MARTINEC J
      HER2 NEU OVEREXPRESSION IS ASSOCIATED WITH TREATMENT FAILURE IN WOMENWITH HIGH-RISK STAGE-II AND STAGE IIIA BREAST-CANCER (GREATER-THAN-10INVOLVED LYMPH-NODES) TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOLLOWING STANDARD-DOSE ADJUVANT CHEMOTHERAPY/

      Clinical cancer research
    65. LEONARD RCF
      HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER

      European journal of cancer
    66. STRUMBERG D; HARSTRICK A; DOLL K; HOFFMANN B; SEEBER S
      BENDAMUSTINE HYDROCHLORIDE ACTIVITY AGAINST DOXORUBICIN-RESISTANT HUMAN BREAST-CARCINOMA CELL-LINES

      Anti-cancer drugs
    67. JOENSUU H
      AUTOLOGOUS STEM-CELL TRANSPLANTATION IN BREAST-CANCER

      Annals of medicine
    68. GRENMAN SE; RANTANEN VT; SALMI TA
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN ADVANCED OVARIAN-CANCER

      Annals of medicine
    69. CAMERON DA; LEONARD RCF
      THE CASE FOR HIGH-DOSE ADJUVANT CHEMOTHERAPY IN BREAST-CANCER .2. CLINICAL-EXPERIENCE

      European journal of surgical oncology
    70. ANTOINE EC; KHAYAT D
      EUROPEAN-SCHOOL-OF-ONCOLOGY EUROPEAN CONSENSUS ON THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR - THE EXAMPLE OF BREAST-CANCER

      Cancer chemotherapy and pharmacology
    71. HANSEN F; MOLLER P; SKOVSGAARD T
      PHASE-II STUDY OF 2ND-LINE TREATMENT WITH HIGH-DOSE CYCLOPHOSPHAMIDE IN RECURRENT METASTATIC BREAST-CANCER

      Cancer chemotherapy and pharmacology
    72. WRIGHTBROWNE V; HORTOBAGYI GN
      HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER - 20 YEARS LATER - WHOM SHOULD WE TREAT - AND WHEN

      Tumori
    73. DEMIRER T; BUCKNER CD; APPELBAUM FR; CLIFT R; STORB R; MYERSON D; LILLEBY K; ROWLEY S; BENSINGER WI
      HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER

      Bone marrow transplantation
    74. BITRAN JD; SAMUELS B; KLEIN L; HANAUER S; JOHNSON L; MARTINEC J; HARRIS E; KEMPLER J; WHITE W
      TANDEM HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS YIELDS PROLONGED SURVIVAL IN STAGE-IV BREAST-CANCER

      Bone marrow transplantation
    75. MARKMAN M
      IFOSFAMIDE IN THE TREATMENT OF OVARIAN-CANCER

      Seminars in oncology
    76. NICHOLS CR
      IFOSFAMIDE IN THE TREATMENT OF GERM-CELL TUMORS

      Seminars in oncology
    77. BEARMAN SI; SHPALL EJ; JONES RB; CAGNONI PJ; ROSS M
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOR METASTATIC AND HIGH-RISK PRIMARY BREAST-CANCER

      Seminars in oncology
    78. CAPITAN EM
      SEARCHING OF ELDORADO - BREAST-CANCER AND INTENSIFICATION CHEMOTHERAPY

      Medicina Clinica
    79. DIETL J
      TYPICAL ASPECTS OF OVARIAN-CARCINOMA

      Geburtshilfe und Frauenheilkunde
    80. JONES A
      ADJUVANT TREATMENT IN HIGH-RISK BREAST-CANCER

      British Journal of Hospital Medicine
    81. GRADISHAR WJ; TALLMAN MS; ABRAMS JS
      HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER

      Annals of internal medicine
    82. KENNEDY MJ; HESS AD
      AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE

      Medical oncology
    83. PICCART MJ; RAYMOND E; AAPRO M; EISENHAUER EA; CVITKOVIC E
      CYTOTOXIC AGENTS WITH ACTIVITY IN BREAST-CANCER PATIENTS PREVIOUSLY EXPOSED TO ANTHRACYCLINES - CURRENT STATUS AND FUTURE-PROSPECTS

      European journal of cancer
    84. STEWARD WP
      HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC SUPPORT FOR BREAST-CANCER

      European journal of cancer
    85. LEONARD RCF
      THE IMPORTANCE OF DOSE AND SCHEDULE IN CANCER-CHEMOTHERAPY - BREAST-CANCER

      Anti-cancer drugs
    86. VONSCHILLING C; HERRMANN F
      DOSE-INTENSIFIED TREATMENT OF BREAST-CANCER - CURRENT RESULTS

      Journal of molecular medicine
    87. AYASH LJ; WHEELER C; FAIRCLOUGH D; SCHWARTZ G; REICH E; WARREN D; SCHNIPPER L; ANTMAN K; FREI E; ELIAS A
      PROGNOSTIC FACTORS FOR PROLONGED PROGRESSION-FREE SURVIVAL WITH HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR ADVANCED BREAST-CANCER

      Journal of clinical oncology
    88. KENNEDY MJ; ARMSTRONG DK; HUELSKAMP AM; OHLY K; CLARKE BV; COLVIN OM; GROCHOW LB; CHEN TL; DAVIDSON NE
      PHASE-I AND PHARMACOLOGICAL STUDY OF THE ALKYLATING AGENT MODULATOR NOVOBIOCIN IN COMBINATION WITH HIGH-DOSE CHEMOTHERAPY FOR THE TREATMENTOF METASTATIC BREAST-CANCER

      Journal of clinical oncology
    89. WRIGHT JE; ELIAS A; TRETYAKOV O; HOLDEN S; ANDERSEN J; WHEELER C; SCHWARTZ G; ANTMAN K; ROSOWSKY A; FREL E; AYASH LJ
      HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE PHARMACOKINETICS - CORRELATION OF PLASMA DRUG LEVELS WITH RENAL TOXICITY

      Cancer chemotherapy and pharmacology
    90. ELIAS AD; AYASH LJ; WHEELER C; SCHWARTZ G; TEPLER I; GONIN R; MCCAULEY M; MAZANET R; SCHNIPPER L; FREI E; ANTMAN KH
      PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT

      Bone marrow transplantation
    91. MARKMAN M
      DIFFICULTIES DEFINING THE ROLE OF HIGH-DOSE CHEMOTHERAPY IN THE MANAGEMENT OF BREAST-CANCER

      Journal of cancer research and clinical oncology
    92. FRENKEL J; KOOL G; DEKRAKER J
      ACUTE-RENAL-FAILURE IN HIGH-DOSE CARBOPLATIN CHEMOTHERAPY

      Medical and pediatric oncology
    93. HUG V; CLARK J; JOHNSTON D
      THE RESULTS OF MODIFIED USE OF CHEMOTHERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER

      European journal of cancer
    94. WONG K; HENDERSON IC
      MANAGEMENT OF METASTATIC BREAST-CANCER

      World journal of surgery
    95. VOGEL CL; GOMEZ EG
      A PHASE-I CLINICAL-TRIAL OF A COMBINATION OF MITOXANTRONE, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN GIVEN ON A DAY 1 AND DAY 8 SCHEDULE TO PATIENTS WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    96. GLUCK S; GAGNON A
      NEUTROPENIC FEVER IN PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AND HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

      Bone marrow transplantation
    97. ELIAS AD; AYASH LJ; WHEELER C; SCHWARTZ G; TEPLER I; MCCAULEY M; MAZANET R; SCHNIPPER L; FREI E; ANTMAN KH
      HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT - SAFETY AND FUTURE-DIRECTIONS/

      Seminars in oncology
    98. LLUCH A; AZAGRA P; CERVANTES A; MUNOZ M; ALBEROLA V; SANTABARBARA P; GARCIACONDE J
      PHASE-II TRIAL OF CISPLATIN AND ETOPOSIDE AS FIRST-LINE THERAPY IN METASTATIC BREAST-CARCINOMA

      Oncology
    99. BUDMAN DR; CITRON ML
      ADJUVANT THERAPY FOR BREAST-CANCER

      Clinical obstetrics and gynecology
    100. SUTTON G
      CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER - AN OVERVIEW

      Clinical obstetrics and gynecology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 09:32:02